Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry.
暂无分享,去创建一个
Benjamin M. Smith | J. Reinhardt | D. Couper | G. Criner | N. Hansel | R. Barr | M. Dransfield | R. Paine | R. Kanner | J. Krishnan | S. Lazarus | P. Woodruff | A. Comellas | R. Buhr | J. Boscardin | R. Kaner | B. Dolezal | V. Ortega | I. Barjaktarevic | D. Tashkin | J. Ohar | S. Rennard | M. Drummond | C. Doerschuk | W. Mckleroy | M. Arjomandi | J. Curtis | R. Bowler | C. Cooper | W. Anderson | T. Shing | F. Martinez | M. Han | E. Bleecker | S. Peters | E. Hoffman | H. A. Awan | Kinsey Helton
[1] Meilan K. Han,et al. Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function. , 2022, The New England journal of medicine.
[2] Ahmed Jamal,et al. Tobacco Product Use Among Adults — United States, 2020 , 2022, MMWR. Morbidity and mortality weekly report.
[3] A. Jemal,et al. Association between disparities in intergenerational economic mobility and cause-specific mortality among Black and White persons in the United States. , 2021, Cancer epidemiology.
[4] D. Harris,et al. Health Disparities in Environmental and Occupational Lung Disease. , 2020, Clinics in chest medicine.
[5] Meilan K. Han,et al. Contribution of Individual and Neighborhood Factors to Racial Disparities in Respiratory Outcomes. , 2020, American journal of respiratory and critical care medicine.
[6] Benjamin M. Smith,et al. Association of Dysanapsis With Chronic Obstructive Pulmonary Disease Among Older Adults. , 2020, JAMA.
[7] Benjamin M. Smith,et al. Association of Nonobstructive Chronic Bronchitis With Respiratory Health Outcomes in Adults. , 2020, JAMA internal medicine.
[8] Kevin McCarthy,et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement , 2019, American journal of respiratory and critical care medicine.
[9] David Couper,et al. Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality. , 2019, JAMA.
[10] J. Curtis,et al. Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS , 2019, Chest.
[11] Raúl San José Estépar,et al. Respiratory Symptoms in Young Adults and Future Lung Disease. The CARDIA Lung Study , 2018, American journal of respiratory and critical care medicine.
[12] W. Bailey,et al. Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years , 2018, Thorax.
[13] Meilan K. Han,et al. Variability in objective and subjective measures affects baseline values in studies of patients with COPD , 2017, PloS one.
[14] F. Herth,et al. The Modern Art of Reading Computed Tomography Images of the Lungs: Quantitative CT , 2017, Respiration.
[15] E. Hoffman,et al. Airway Mucin Concentration as a Marker of Chronic Bronchitis , 2017, The New England journal of medicine.
[16] Meilan K. Han,et al. Frequency of Exacerbations in COPD: An Analysis of the SPIROMICS Cohort , 2017, The Lancet. Respiratory medicine.
[17] Richard W. Bohannon,et al. Minimal clinically important difference for change in 6‐minute walk test distance of adults with pathology: a systematic review , 2017, Journal of evaluation in clinical practice.
[18] D. Postma,et al. Parametric response mapping on chest computed tomography associates with clinical and functional parameters in chronic obstructive pulmonary disease. , 2017, Respiratory medicine.
[19] David Couper,et al. SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs. , 2016, American journal of respiratory and critical care medicine.
[20] Robert Paine,et al. Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function. , 2016, The New England journal of medicine.
[21] V. Kim,et al. Comparison between an alternative and the classic definition of chronic bronchitis in COPDGene. , 2015, Annals of the American Thoracic Society.
[22] Q. Hou,et al. Assessment of Health Status in Patients with Newly Diagnosed Chronic Obstructive Pulmonary Disease , 2013, PloS one.
[23] C. Nejjari,et al. Psychometric evaluation of the COPD assessment test: data from the BREATHE study in the Middle East and North Africa region. , 2012, Respiratory medicine.
[24] P. Jones,et al. Creating scenarios of the impact of copd and their relationship to copd assessment test (CAT™) scores , 2011, BMC pulmonary medicine.
[25] Asger Dirksen,et al. Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. , 2010, American journal of respiratory and critical care medicine.
[26] P. Jones,et al. Development and first validation of the COPD Assessment Test , 2009, European Respiratory Journal.
[27] D. Jarvis,et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. , 2007, American journal of respiratory and critical care medicine.
[28] J L Hankinson,et al. Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.